Catalyst Wire Dossier Catalyst Wire Dossier

aminolevulinic acid photodynamic therapy

aminolevulinic acid photodynamic therapy · Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for aminolevulinic acid photodynamic therapy, covering 2017-09-21 to 2019-07-08. Get the full timeline:

Most recent: Clinical Trial Update: Aminolaevulinic Acid Photodynamic Therapy for HPV+ Low Grade Cervical Intraepithelial Neoplasia (LSIL;CIN1) [Phase 2]

See pricing